Cargando…
Interferon-inducer antivirals: Potential candidates to combat COVID-19
Coronavirus disease 2019 (COVID-19) is an infective disease generated by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Given the pandemic urgency and lack of an effective cure for this disease, drug repurposing could open the way for finding a solution. Lots of investigations are ong...
Autores principales: | Bagheri, Ashkan, Moezzi, Seyed Mohammad Iman, Mosaddeghi, Pouria, Nadimi Parashkouhi, Sadra, Fazel Hoseini, Seyed Mostafa, Badakhshan, Fatemeh, Negahdaripour, Manica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705326/ https://www.ncbi.nlm.nih.gov/pubmed/33348292 http://dx.doi.org/10.1016/j.intimp.2020.107245 |
Ejemplares similares
-
Administration of COVID-19 vaccines in immunocompromised patients
por: Negahdaripour, Manica, et al.
Publicado: (2021) -
Harnessing the non-specific immunogenic effects of available vaccines to combat COVID-19
por: Mosaddeghi, Pouria, et al.
Publicado: (2020) -
Deep survey for designing a vaccine against SARS-CoV-2 and its new mutations
por: Vakili, Bahareh, et al.
Publicado: (2021) -
The Rise and Fall in Therapeutic Candidates for COVID-19
por: Negahdaripour, Manica
Publicado: (2020) -
Identification of hub pathways and drug candidates in gastric cancer through systems biology
por: Salarikia, Seyed Reza, et al.
Publicado: (2022)